Literature DB >> 31408800

Altered microRNA processing proteins in HPV-induced cancers.

Barbara C Snoek1, Iris Babion1, Danijela Koppers-Lalic2, Dirk M Pegtel1, Renske Dm Steenbergen3.   

Abstract

High-risk human papilloma virus (hrHPV) infections are associated with the development of anogenital cancers, in particular cervical cancer, and a subset of head and neck cancers. Previous studies have shown that microRNAs (miRNAs) contribute to the development and progression of HPV-induced malignancies. miRNAs are small non-coding RNAs that exist as multiple length and sequence variants, termed isomiRs. Efficient processing of miRNAs and generation of isomiRs is accomplished by several processing proteins. Deregulation of Drosha, AGO2, and TENT2, among others, has been observed in HPV-induced cancers and was even found at the precancerous stage. This suggests that miRNA processing proteins may be involved during early cancer development and that the generated isomiRs could provide promising biomarkers for early cancer diagnosis.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31408800     DOI: 10.1016/j.coviro.2019.07.002

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  3 in total

1.  The distance distribution of human microRNAs in MirGeneDB database.

Authors:  Hsiuying Wang
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 2.  HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.

Authors:  Lulu Yu; Vladimir Majerciak; Zhi-Ming Zheng
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

Review 3.  Beyond MicroRNAs: Emerging Role of Other Non-Coding RNAs in HPV-Driven Cancers.

Authors:  Mariateresa Casarotto; Giuseppe Fanetti; Roberto Guerrieri; Elisa Palazzari; Valentina Lupato; Agostino Steffan; Jerry Polesel; Paolo Boscolo-Rizzo; Elisabetta Fratta
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.